Evaluating the efficacy of dissolving xylitol chewable tablets versus xylitol chewing gum on bacterial count, plaque accumulation and gingival inflammation in senior citizens.

A randomized double-blind, parallel, clinical trial evaluating the efficacy of dissolving xylitol chewable tablets versus xylitol chewing gum on bacterial count, plaque accumulation and gingival inflammation in senior citizens. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/089570

Enrollment

Registered

2025-06-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K051- Chronic gingivitis

Interventions

Intervention1: xylitol-dissolving chewable tablets: Listerine Ready Tabs Intervention Group: Xylitol Dissolving Tablets Frequency: 1 tablet, 3 times daily (morning, afternoon, evening) Total Duration:

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria involved at least 20 natural teeth and mild to moderate gingival inflammation.

Exclusion criteria

Exclusion criteria: Subjects with systemic illness impacting oral health, history of known allergy to xylitol, or intake of antibiotics or antimicrobial mouthwashes over the last three months were excluded.

Design outcomes

Primary

Measure	Time frame
Bacterial count,Plaque accumulation, Gingival inflammationTimepoint: 0-30 days	—

Secondary

Measure	Time frame
salivary pH or flow rateTimepoint: 0-30 days	—

Countries

India

Contacts

Public ContactDr Tannu Kumari

Teerthanker mahaveer dental college and research centre

drpradeeptangade.dental@tmu.ac.in9997466339

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026